Evotec
Kenneth Roberts is a seasoned scientist with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as a Senior Scientist and Mass Spectrometry Screening Group Leader at Evotec since November 2016, Kenneth also held the position of Associate Researcher. Prior to this role, Kenneth worked as a Scientist at Merck for a brief period in 2016 and served as a Research Laboratory Technician at the University of Pennsylvania from May 2015 to June 2016. Kenneth's earlier experience includes multiple roles at Merck, Absorption Systems, LP, Wyeth Pharmaceuticals, and GSK, where Kenneth developed a strong foundation in scientific research and laboratory management. Kenneth holds a Bachelor of Science degree in Bioscience and Biotechnology from Drexel University, earned between 1996 and 2001.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.